SLC22A20P (Gene)

Entrez:440044

Description:solute carrier family 22 member 20, pseudogene

Predicted to enable transmembrane transporter activity. Predicted to be involved in ion transport and transmembrane transport. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View SLC22A20P's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with SLC22A20P.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using SLC22A20P.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for SLC22A20P.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with SLC22A20P.

Results found

Linked to

	Label	Description
	GSE239844 crizotinib 1 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE77108 saha 6 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE113369 p53 inhibition 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE128730 neratinib OVCAR-8 4 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 10 v 14 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE244730 erlotinib PC-9 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE189859 GSE189861 IDH1 knockout 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE218773 ABL2 knockdown Hep-G2 2 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE160182 GSE160183 IKAROS GFI1 knockout 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE189859 GSE189861 IDH1 knockout 4 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS

GSE239844 crizotinib 1 v 10 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE77108 saha 6 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE113369 p53 inhibition 2 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE128730 neratinib OVCAR-8 4 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 10 v 14 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE244730 erlotinib PC-9 0 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE189859 GSE189861 IDH1 knockout 0 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE218773 ABL2 knockdown Hep-G2 2 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE160182 GSE160183 IKAROS GFI1 knockout 2 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE189859 GSE189861 IDH1 knockout 4 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.